Postpartum Hemorrhage Following Prolonged Induction and Cesarean Delivery: Rapid Blood Product Delivery with LifeFlow Supports Hemodynamic Stabilization and Uterine Preservation

Case Summary

A 32-year-old G1P0 female developed severe postpartum hemorrhage following prolonged induction of labor, ultimately requiring cesarean delivery. Her estimated intraoperative blood loss was approximately 1200mL, and in the immediate postoperative period she developed escalating hemorrhage with total blood loss approaching 4 liters.

Recognizing impending circulatory collapse due to ongoing hemorrhage, the bedside nurse activated the Massive Transfusion Protocol (MTP) and initiated rapid blood administration using LifeFlow. She received 6 units of PRBCs, along with plasma, cryoprecipitate, and platelets as part of balanced resuscitation. The patient was taken emergently to the operating room, where surgical hemorrhage control was achieved without the need for hysterectomy.

This case highlights the importance of immediate recognition of postpartum hemorrhage and rapid restoration of circulating volume using a simple and intuitive manual rapid infusion technology.

 

Initial Presentation

The patient underwent induction for approximately two days prior to cesarean section and was receiving oxytocin and magnesium therapy. Following delivery, she developed progressive hemodynamic instability due to hemorrhage. Her initial vital signs included hypotension (BP 70’s/30’s), HR 110, pallor, and complaint of nausea. Her vascular access was initially limited to a 20-gauge IV, but a second 18-gauge IV was subsequently obtained.

Since she was demonstrating signs of severe postpartum hemorrhagic shock and impending hemodynamic collapse, and rapid resuscitation with blood products was initiated to stabilize her prior to return to the OR for hemorrhage control.

 

Resuscitation Strategy and LifeFlow Utilization

Her bedside nurse recognized the severity of her patient’s condition and activated MTP while her partners prepared Pitocin and TXA and inserted a JADA intrauterine hemorrhage control device.  She began the transfusion using LifeFlow, delivering 6 units of PRBCs and 2u FFP through her peripheral IV, after which her blood pressure improved to 118/80, HR came down to 80, and her skin color improved.  She also received cryoprecipitate and platelets, and the anesthesia team determined that additional transfusion was not required at that time.

 

Definitive Management and Outcome

The patient then returned to the operating room for definitive hemorrhage control. Rapid restoration of circulating volume enabled the surgical team to proceed safely, resulting in effective surgical hemorrhage control, preservation of her uterus, and discharge home within several days.

Immediate access to blood products, along with a simple technology for rapid delivery, played a critical role in helping the team move quickly from hemorrhage recognition to definitive surgical management.

 

Clinician Feedback

Bedside clinicians specifically noted that delayed blood administration could have resulted in loss of consciousness, hysterectomy, or even maternal death.  They also reported that:

  • LifeFlow was significantly easier and more intuitive than traditional rapid infusers
  • Recent staff training supported immediate device adoption without hesitation
  • Faster blood delivery was perceived as directly contributing to preservation of life and uterus

 

Clinical Discussion

Postpartum hemorrhage remains a leading cause of maternal morbidity and mortality worldwide. Favorable outcomes depend heavily on time to recognition of severe hemorrhage, immediate blood product delivery, and the ability to transfuse blood quickly.

Since vascular access is often limited to smaller gauge peripheral IV’s early in obstetric hemorrhage, a technology capable of intuitively delivering rapid transfusion through peripheral lines can significantly reduce time to effective resuscitation.

Postpartum hemorrhage can progress to life-threatening shock. This case reinforces the critical importance of early recognition of shock, immediate efforts at hemorrhage control, activation of massive transfusion protocols, and the ability to rapidly deliver blood products through readily available peripheral vascular access. Rapid restoration of circulating volume and oxygen-carrying capacity provides a vital bridge to definitive hemorrhage control, directly contributing to improved outcomes including maternal survival and preservation of the uterus.